Mesothelioma - Causes, Symptoms, and Treatment

Posted by Guest Blogger on Dec 13, 2016 10:30:00 AM

This post was contributed by the Mesothelioma Cancer Alliance.

We have learned much about the causes of cancer and the different avenues that can be used to treat it. For those who are running out of hope with more traditional treatments, such as surgery, radiation, and chemotherapy, immunotherapy is coming to the fore as a cutting edge form of cancer treatment. With the goal of the Cancer Moonshot Initiative being to cure cancer, more funding and research opportunities are being provided to immunotherapy than ever before. Although different types of cancer have different challenges and obstacles to overcome, mesothelioma sufferers can see great promise in up and coming treatments like immunotherapy.

Read More >

Topics: Cancer

Plasmid Grant to Aid Cervical Cancer Screening in Ghana

Posted by Tyler Ford on Nov 8, 2016 10:30:00 AM

Gladys Kaba from the University of Health and Allied Sciences in Ghana will be receiving the third Addgene/Seeding Labs plasmid grant and plans to use the grant to order plasmids she can use as positive controls in PCR-based cervical cancer screens.

Read More >

Topics: Investigator Feature, Cancer

Addgene's Cancer Collection Pages Connect the Research Community

Posted by Michael G. Lemieux on Sep 6, 2016 10:30:00 AM

Cancer – a term familiar to almost every person regardless of profession, race, or gender. Almost no other disease receives as many billions of dollars in funding or as much attention collectively from researchers. Scientists, however, have yet to slay the beast. On a global scale, tens of millions of new cancer cases arise and millions of people die from cancer-related complications each year. Despite these grim statistics, new strategies for attacking cancer are yielding promising results in the laboratory, and Addgene is accelerating this research by helping to make new cancer resources easily accessible to the research community.

Read More >

Topics: Cancer

Modulate the Activity of 17 Signaling Pathways with One Kit!

Posted by Kendall Morgan on Mar 22, 2016 10:30:00 AM

When cancers are treated with drugs designed to hit them right where it hurts, the effects are often remarkable but fleeting.

“What’s been shown by others is that, in a relatively short amount of time, cancers become resistant to drugs, particularly targeted therapies,” said Kris Wood of Duke University Medical Center. “While we do not yet have a comprehensive understanding of how cancers become resistant, an emerging theme is that they do so by activating signaling pathways controlling properties like growth, survival, and differentiation.”

Read More >

Topics: Plasmid Technology, Cancer, Plasmid Kits

New Tool for Lineage Tracing: The ClonTracer Library

Posted by Tyler Ford on Sep 22, 2015 10:30:00 AM

This article is based on an interview with Novartis researcher, Carrie Bhang.

The ClonTracer Library, deposited by Carrie Bhang, a research investigator in the In Vivo Pharmacology group at Novartis Oncology, is an exciting new tool that allows researchers to individually label millions of mammalian cells through lentiviral infection and to monitor their abundance and clonal dynamics over time using next generation sequencing (NGS). The library was developed when Carrie was a post-doc in Frank Stegmeier’s lab in Novartis Oncology. 

Read More >

Topics: Interview, Viral Vectors, pooled libraries, Cancer

Subscribe to Our Blog